This case is notable because the patient had previously tolerated dulaglutide without any injection site reactions, emphasizing that tolerance to one GLP-1 agonist does not predict tolerance to another
doi:10.1080/09513590.2018.1431769 [47] Ng CM, Blackman MR, Wang C, Swerdloff RS
Other common issues include diarrhea, vomiting, constipation, and abdominal pain
"Any promotional activity, including so-called awareness campaigns that function as a surrogate advertisement for prescription-only drugs, shall be viewed seriously and may be treated as an irrational or misleading marketing practice," the advisory stated
Syringes and needles for injection ordered separately.